CiiTA provides expert solutions to the complex issues affecting stakeholders in the 340B and Medicaid Drug Rebate programs. Our founders have been at the forefront of 340B innovation for two decades, and CiiTA leverages this experience to provide transparency and neutral reporting in the federal pharmacy market. Our novel technology platform delivers value to our clients while reducing administrative burden and increasing program compliance for all stakeholders. To learn how we can help you, please visit www.ciitainc.com.